MedicWatchAn independent record

GPHC determination — substantive hearing

Suspended from practice — 1 year

The regulator’s term: suspension

What does “suspended from practice” mean?

A suspension is a fixed-term pause on the right to practise. The practitioner cannot work in the regulated profession during the suspension. At the end of the period the suspension may be extended, replaced with another sanction, or lifted on review.

Concerning Sylvester Emmanuel Vinkabb Jr, pharmacist (GPHC 2211346).

Decision date: 12 December 2024 · Hearing started 9 December 2024 and ended 12 December 2024

This sanction period has elapsed.

In plain English

The GPhC committee decided that Sylvester Emmanuel Vinkabb Jr should be subject to the published outcome from a principal hearing in a misconduct case. The committee imposed a suspension for 12 months. It records fitness to practise as impaired. The official determination gives the committee's reasons, order wording, and any conditions attached to the decision.

Charges

The GPhC allegation section states: “You, a registered Pharmacist, whilst employed at Evans Pharmacy, Long Eaton, Derbyshire (“the Pharmacy”): 1. Between May 2022 and February 2023, ordered and removed approximately 211 x boxes of 60 tablets x 0.5mg of Xanax from the Pharmacy; 2. Between May 2022 and February 2023, ordered and removed approximately 123 x boxes of 28 tablets x 10mg of Diazepam from the Pharmacy; 3. Between September 2022 and February 2023, ordered and removed approximately 9 x 2 litre bottles of Codeine Linctus from the Pharmacy; 4. Between May 2022 and March 2023, ordered and removed approximately 472 x 200ml bottles of Codeine Linctus from the Pharmacy; 5. Between February 2022 and February 2023, ordered and removed approximately 357 x 100 ml bottles of Phenergan Elixir from the Pharmacy; 6. In respect of allegations 1 to 5 above, having removed these high-risk medicines liable to abuse, misuse or overuse from the Pharmacy, supplied them onwards: 6.1 without the authority of: (a) a wholesale distribution licence; [ADMITTED] (b) a Home Office controlled drugs licence (including in respect of export); [ADMITTED] (c) a UK legally valid prescription; [ADMITTED] 6.2 without any or any adequate guarantee that consumption by end users would be subject to effective clinical oversight; [NOT ADMITTED] 7. In respect of allegations 1 to 5 above, were dishonest, in that: 7.1 you knew that you did not have the permission of your employer to order and / or remove medicines other than for the purposes of the Pharmacy’s business; 7.2 you knew that you did not have a UK valid prescription in respect of the prescription-only medication; [DISHONESTY DENIED] 3 And by reason of the matters set out above, your fitness to practise is impaired by reason of your misconduct”.

Findings

The GPhC Fitness to Practise Committee held a principal hearing for Sylvester Emmanuel Vinkabb Jr in a misconduct case. The cover page records facts proved: Particulars 1, 2, 3, 4, 5, 6, 6.2, 7, 7.1 and 7.2 Facts proved by Admission: Particulars 6.1a), b) and c). It records fitness to practise as impaired. The committee imposed a suspension for 12 months.

Source

All facts on this page are drawn from the publicly published GPHC determination linked below. MedicWatch does not editorialise the regulator’s findings.

Spot something incorrect?

If a fact on this page is wrong, or you believe the page should not be published, please submit a correction or takedown request.